Exploring the Fundamentals of Refractive Surgery

Speciality: Surgery


Speaker:

Dr. Ridhima Bhagali | Consultant Cataract and Refractive Surgeon

Description:

A warm welcome to all the medical professionals in this interesting session on understanding the fundamentals of refractive surgery.

Refractive surgery is a type of surgical procedure aimed at correcting vision problems, such as nearsightedness (myopia), farsightedness (hyperopia), and astigmatism. During refractive surgery, the shape of the cornea or the lens inside the eye is altered to improve the way light rays focus on the retina, resulting in clearer vision without the need for corrective lenses. Common types of refractive surgery include LASIK (Laser-Assisted in Situ Keratomileusis), PRK (Photorefractive Keratectomy), and SMILE (Small Incision Lenticule Extraction). These procedures are performed by ophthalmologists, who carefully evaluate the patient's eye health and visual acuity before recommending the most suitable surgical approach.

Refractive surgery aims to reduce or eliminate dependence on glasses or contact lenses, allowing individuals to enjoy improved vision and greater freedom in their daily activities. Candidates for refractive surgery should have stable vision and meet certain criteria, such as age, corneal thickness, and overall eye health. Before surgery, patients undergo a comprehensive eye examination to assess their suitability for the procedure and discuss the potential risks and benefits. Refractive surgery offers long-lasting results and high patient satisfaction rates, making it a popular choice for individuals seeking permanent vision correction.

Therefore, it provides an overall knowledge on understanding the fundamen

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why preventive mastectomy isn't offered to everyone at risk

2.

Financial hardship common in patients with cancer

3.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

4.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

5.

Severe obesity associated with reduced prevalence of recommended cancer screenings


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot